Stocks of Elanco Animal Health Inc (NYSE:ELAN) traded higher last session on Wall Street, up 3.10% to $14.96.
ELAN stock price is now 9.87% away from the 50-day moving average and 22.29% away from the 200-day moving average. The market capitalization of the company currently stands at $7.43B.
With the price target maintained at $18, Leerink Partners recently Upgraded its rating from Market Perform to Outperform for Elanco Animal Health Inc (NYSE: ELAN). , while ‘UBS’ rates the stock as ‘Buy’
In other news, Kurzius Lawrence Erik, Director bought 10,000 shares of the company’s stock on Mar 07 ’25. The stock was bought for $109,000 at an average price of $10.90. Upon completion of the transaction, the Director now directly owns 101,459 shares in the company, valued at $1.52 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 11 ’25, Director Kurzius Lawrence Erik bought 10,000 shares of the business’s stock. A total of $102,000 was incurred on buying the stock at an average price of $10.20. This leaves the insider owning 111,459 shares of the company worth $1.67 million. A total of 0.94% of the company’s stock is owned by insiders.
During the past 12 months, Elanco Animal Health Inc has had a low of $8.02 and a high of $15.78. As of last week, the company has a debt-to-equity ratio of 0.69, a current ratio of 2.71, and a quick ratio of 1.46. According to the stock market information, the enterprise value for the company is $11000112128, which is based on a 19.97 price-to-earnings ratio, a 3.11 price-to-earnings-growth ratio, and a beta of 1.67. The fifty day moving average price for ELAN is $13.3124 and a two-hundred day moving average price translates $12.21875 for the stock.
The latest earnings results from Elanco Animal Health Inc (NYSE: ELAN) was released for 2025-03-31. The net profit margin was 8.43% and return on equity was 6.01% for ELAN.
